# Toku Eyes jobs and careers

> 0 open roles at Toku Eyes as of October 24, 2026. Source: https://www.thejobsmap.com/company/toku-eyes

Toku is creating a world focused on preventive healthcare, using the eye as a window to our health. We believe every person in the world should have access to early diagnosis of health conditions before it’s too late. How? by developing tools using AI and retinal images to enable accessible healthcare for early and accurate diagnosis of health conditions to empower everyday individuals. The retina has long been recognized as a unique window into an individual’s health, as the biomarkers present in retinal images may provide valuable insights into aging, inflammatory health, neurological health, and cardiovascular health. BioAge Not all people age equally. Every person has two ages: our chronological age (how old you are) and our biological age. Biological age (or BioAge) is a measure of how well our cells, tissues and organs are aging. Toku’s BioAge product determines a person’s biological age, which can give an indication of their overall health, by looking at vascular, metabolic, inflammatory and lifestyle indicators present in the retinal image. By knowing our BioAge earlier, we can make conscious health choices to improve our health. Unlike our chronological age, our BioAge is not fixed. BioAge uses retinal images and hence is non-invasive, time efficient, cost effective, and can be delivered by trusted healthcare providers. The retinal vasculature allows direct non-invasive visualization of the body’s microvasculature, as it is the only part of the body where scientists and clinicians can directly assess the health of an individual’s neuro-vascular tissues. Toku’s AI platform utilizes a revolutionary, patented method to evaluate more than 23 million technical parameters and 12 biological parameters in each retinal image, to produce a BioAge outcome. The AI engine has learned patterns from images from over 1.3 million retinal images to recognize the various features of health. Cardiovascular Screening (CLAiR) Cardiovascular disease is the leading caus

## Key facts

| | |
|---|---|
| Open roles | 0 |
| Headquarters | Auckland, Auckland, New Zealand |
| Founded | 2018 |
| Employees | 1 to 10 |
| Total funding | $13M |
| Industries | AI/ML, Biotechnology, Health Care, Health Diagnostics |
| Website | https://tokueyes.com |

## Leadership

- Ehsan Vaghefi, Co-founder
- Michael V. McConnell, Chief Health Officer
- Yariv L., Chief Compliance Officer
- Kai C., Senior Software Engineer
- Gerard Wallace, Exec Director / People Officer
- Kate Blackbourn, Chief Product Officer
- Francesca Logan, Chief Commercial Officer

## Common questions

### Is Toku Eyes hiring right now?

Toku Eyes has no open roles listed as of October 24, 2026. Roles appear here as soon as they are posted on Toku Eyes's careers site.

### Where is Toku Eyes headquartered?

Toku Eyes is headquartered in Auckland, Auckland, New Zealand and was founded in 2018.

### Who leads Toku Eyes?

Ehsan Vaghefi, Co-founder, is at the top of Toku Eyes's org chart.

### How do I apply for a job at Toku Eyes?

Pick a role on Toku Eyes's TheJobsMap page and select Apply. Every listing links to the original posting on Toku Eyes's own careers site, so you apply directly with the employer.